A study in healthy subjects to assess the pharmacokinetics of savolitinib when administered alone and in combination with rifampicin

Trial Identifier:	D5084C00003
Sponsor:	AstraZeneca
NCTID::	NCT04118842
Start Date:	October 2019
Primary Completion Date:	February 2020
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MD	Baltimore, MD, United States of America, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.